FY2025 EPS Estimates for FDMT Increased by Cantor Fitzgerald
4D Molecular Therapeutics, Inc. (NASDAQ:FDMT – Free Report) – Stock analysts at Cantor Fitzgerald upped their FY2025 earnings per share (EPS) estimates for 4D Molecular Therapeutics in a research note issued on Tuesday, March 4th. Cantor Fitzgerald analyst J. Schimmer now anticipates that the company will post earnings per share of ($3.22) for the year, […]
4D Molecular Therapeutics, Inc. (NASDAQ:FDMT – Free Report) – Stock analysts at Cantor Fitzgerald upped their FY2025 earnings per share (EPS) estimates for 4D Molecular Therapeutics in a research note issued on Tuesday, March 4th. Cantor Fitzgerald analyst J. Schimmer now anticipates that the company will post earnings per share of ($3.22) for the year, […]
